N. Mallard

A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose‐escalation regimen in patients with erectile dysfunction

M. Hibberd, S. Bukofzer, P. Ströberg, 2002, BJU international.

Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency

B. Bokemeyer, M. Mross, S. Howaldt, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition

D. Macmahon, A. Johnston, T. Corn, 2003, Journal of Neural Transmission.

A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition

F. Hartig, T. Corn, A. Clarke, 2003, Journal of Neural Transmission.

Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial

D. Craufurd, B. Landwehrmeyer, J. Ferreira, 2015, Movement disorders : official journal of the Movement Disorder Society.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial

D. Craufurd, B. Landwehrmeyer, J. Ferreira, 2015, Movement disorders : official journal of the Movement Disorder Society.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.